Tislelizumab combined with chemotherapy shows promising antitumor activity in advanced cervical cancer, achieving high response rates and manageable safety profiles.

A Lubbock family is speaking out after losing their 35-year-old loved one just 13 months after she was diagnosed with ...

Her new doctor immediately took action, performing a series of tests and soon discovering what others had missed: Avi had ...

A woman who lost her sister to cervical cancer says she saved her life after discovering breast cancer through an early mammogram. Katie Allen, 33, chose to undergo a comprehensive health check-up ...

Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.

Results Detection of HPV-human DNA junctions in cervical cancer patient tumors HPV-human DNA junctions were retrospectively assessed using archived samples from 16 cervical cancer patients (12 ...

New at-home cervical cancer screening kits are coming to England, in the hopes of eradicating the disease by 2040. Here's what the HPV tests look for, how they work ...

Mailed self-collection kits and a telephone reminder helped increase cervical cancer screening (CCS) rates more than twice as much as telephone reminders for an office visit, according to new data ...

Findings of a qualitative study revealed that fear of bad news, a lack of understanding of the risks and benefits, and low socioeconomic position are factors that can discourage cervical screening.

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care team waits for.

Cadonilimab is making significant progress in treating both recurrent/metastatic and locally advanced cervical cancer, establishing a comprehensive therapeutic approach. The positive results from the ...

Adding pembrolizumab to CCRT improved survival outcomes in patients with high-risk, locally advanced cervical cancer.